CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −22,727 | 0 | ||
| 2023-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −9,044 | 9,045 | ||
| 2023-05-04 | Wadsworth Samuel C. Director | Grant or award · Restricted Stock Units | +126,075 | 126,075 | ||
| 2023-05-04 | Frankel Stanley Director | Grant or award · Restricted Stock Units | +126,075 | 126,075 | ||
| 2023-05-04 | Buehler Kevin Director | Grant or award · Restricted Stock Units | +126,075 | 126,075 | ||
| 2023-05-04 | Pire Shari Lisa Director | Grant or award · Restricted Stock Units | +126,075 | 126,075 | ||
| 2023-05-04 | Brown Melinda Director | Grant or award · Restricted Stock Units | +126,075 | 126,075 | ||
| 2023-05-04 | Germano Geno J Director | Grant or award · Restricted Stock Units | +126,075 | 126,075 | ||
| 2023-04-27 | List Alan Chief Medical Officer | Sale 10b5-1 | −7,771 | $0.79 | $6K | 56,496 |
| 2023-04-26 | List Alan Chief Medical Officer | Option exercise 10b5-1 | +26,027 | 64,267 | ||
| 2023-04-26 | List Alan Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −26,027 | 26,028 | ||
| 2023-04-11 | Buehler Kevin Director | Option exercise | +5,701 | 5,701 | ||
| 2023-04-11 | Buehler Kevin Director | Option exercise · Restricted Stock Units | −5,701 | 0 | ||
| 2023-03-22 | Amoroso Michael President and CEO | Sale 10b5-1 | −46,999 | $0.82 | $39K | 68,738 |
| 2023-03-21 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +102,535 | 115,737 | ||
| 2023-03-21 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −102,535 | 205,009 | ||
| 2023-03-17 | Kelly John Alexander Chief Financial Officer | Purchase | +20,000 | $0.86 | $17K | 245,614 |
| 2023-03-06 | Scimeca Dario General Counsel and Secretary | Sale | −12,172 | $1.07 | $13K | 50,063 |
| 2023-03-06 | List Alan Chief Medical Officer | Sale | −9,473 | $1.07 | $10K | 38,240 |
| 2023-03-03 | Scimeca Dario General Counsel and Secretary | Option exercise | +27,558 | 62,235 |
Page 13 of 23 · 456 trades